Blood clots in those with severe Covid-19 may be related to abnormal antibody response

News

Twitter

Facebook

email

A new study of cells provides support and scientific validation for the MATIS clinical trial, led by Imperial College London and Imperial College Healthcare NHS Trust.

Follow this news feed:

Guidance: Farming businesses: working after Brexit transition Guidance: National flu immunisation programme plan

Leave a Reply Cancel reply